Showing results (1131-1140 of 1,447) with videos related to

Sort By:
Pageof 145
The Journal of Biological Chemistry|April 13, 2012
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces death receptor 5 networks that are highly organizedChristopher C Valley, Andrew K Lewis, Deepti J Mudaliar, et al.
Medical Care|February 21, 2018
Maryland Multipayor Patient-centered Medical Home Program: A 4-Year Quasiexperimental Evaluation of Quality, Utilization, Patient Satisfaction, and Provider PerceptionsJill A Marsteller, Yea-Jen Hsu, Christine Gill, et al.
Nature|December 19, 1996
CD22 regulates thymus-independent responses and the lifespan of B cellsK L Otipoby, K B Andersson, K E Draves, et al.
Journal of the National Cancer Institute. Monographs|March 10, 2015
Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancerHeather Greenlee, Lynda G Balneaves, Linda E Carlson, et al.
Plos One|February 6, 2013
Using central IRBs for multicenter clinical trials in the United StatesKathryn E Flynn, Cynthia L Hahn, Judith M Kramer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2013
The focal dystonias: current views and challenges for future researchH A Jinnah, Alfredo Berardelli, Cynthia Comella, et al.
Frontiers in Neurology|April 26, 2021
The Dystonia Coalition: A Multicenter Network for Clinical and Translational StudiesGamze Kilic-Berkmen, Laura J Wright, Joel S Perlmutter, et al.
Journal of Neurology|January 13, 2026
Preferential age-related striatal volume preservation in cervical dystoniaM Owusu-Ansah, A E Morris, A Tanenbaum, et al.
Urology|February 11, 1998
Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: results of a randomized, double-blind, multicenter, sham-controlled trialC G Roehrborn, G Preminger, P Newhall, et al.
Clinical Science (London, England : 1979)|July 18, 2015
β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive ratsMark Del Borgo, Yan Wang, Sanja Bosnyak, et al.
Pageof 145